MedTrace Logo

Different Doses of Nebulized Magnesium Sulphate in Status Asthmaticus

NCT04929626 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 126

Last updated 2023-04-05

No results posted yet for this study

Summary

In this study investigators will use magnesium sulphate in the nebulized form in children between 2 and 12 years of age as an acute reliever for acute severe asthma. Aim of this study is to determine that whether adding low (250mg), intermediate (500mg), and high doses (750mg) of magnesium sulphate in the 1st hour of treatment has any difference in the improvement of clinical condition of the patient and length of hospital stay. There will be total 108 patients having 2 groups. 1st group will receive only Ventolin while 2nd group will be given Ventolin and Magnesium sulphate.

Conditions

  • Status Asthmaticus

Interventions

DRUG

Magnesium Sulfate 500 mg/ml+ ventolin

3 doses of magnesium sulphate i.e; 250mg(0.5ml), 500mg(1ml), 750mg(1.5ml) will be used in nebulized form

DRUG

Ventolin

it will be given to control group in nebulized form after every 20 min in 1st hour

Sponsors & Collaborators

  • Ziauddin University

    lead OTHER

Principal Investigators

  • Rabia Asif, MBBS, PGT · Ziauddin Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2022-11-12
Completion
2022-11-12

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04929626 on ClinicalTrials.gov